Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q5485165> ?p ?o }
Showing triples 1 to 79 of
79
with 100 triples per page.
- Q5485165 description "Founder of Cephalon".
- Q5485165 description "Founder of Cephalon".
- Q5485165 subject Q6647483.
- Q5485165 subject Q7214838.
- Q5485165 subject Q8341432.
- Q5485165 subject Q8645634.
- Q5485165 subject Q8729143.
- Q5485165 subject Q8733292.
- Q5485165 subject Q8745359.
- Q5485165 subject Q8753520.
- Q5485165 subject Q8842160.
- Q5485165 subject Q9155972.
- Q5485165 subject Q9707746.
- Q5485165 abstract "Frank Baldino Jr. (May 13, 1953 – December 16, 2010) was an American pharmacologist and scientist who was one of the co-founders of the pharmaceutical firm Cephalon, a company that was formed in 1987 and had grown to annual sales of $2.8 billion and net income of $425 million in 2010.Baldino was born on May 13, 1953, in Passaic, New Jersey. He grew up in Bergen County, New Jersey and Bucks County, Pennsylvania, graduating from Pennsbury High School. He earned his undergraduate degree at Muhlenberg College and was awarded a doctorate in pharmacology from Temple University. After a Postdoctoral Fellowship in pharmacology at Robert Wood Johnson Medical School in New Jersey, he joined DuPont, where, as a Senior Researcher he investigated prospective pharmaceutical products for the company.After leaving DuPont, Baldino co-founded Cephalon in 1987 at the age of 33. Its best known product has been modafinil, which the firm markets under the brand name Provigil, which has been approved by the Food and Drug Administration for use in treating narcolepsy, shift work sleep disorder and excessive daytime sleepiness resulting from sleep apnea, though the FDA has held off on approving its use for treating jet lag. In marketing Provigil, Baldino emphasized that "there are no warts on this drug" and the product became a best seller for its off-label use by individuals seeking to maintain alertness and combat fatigue without the side effects of caffeine and amphetamines, with off-label uses accounting for 90% of sales by 2004. The current market size of Provigil is over US$1,120 million in 2010 while Nuvigil is expected to reach revenue of US$700 million by 2013 . Baldino said that his "only question is how big we can make it". Brenda D. Gavin of Quaker Bio Ventures credited Baldino as one of the "really, really rare" people who were able to found a company and then build it over the years as its chief executive.Cephalon settled a lawsuit for $17 million in which it faced claims that Baldino and other company executives had overstated the potential for a drug aimed at treating amyotrophic lateral sclerosis (known informally as Lou Gehrig's disease). The Federal Trade Commission claimed that Cephalon had made improper deals to postpone the availability of generic versions of modafinil and the firm paid over $400 million in 2007 in response to allegations that the firm had improperly marketed its pharmaceutical products.A resident of West Chester, Pennsylvania, Baldino had been on leave from his duties at Cephalon starting in August 2010 as he sought medical treatment and his responsibilities were overseen by Chief Operating Officer J. Kevin Buchi. He died at the Hospital of the University of Pennsylvania in Philadelphia at the age of 57 on December 16, 2010, due to complications of leukemia. He was survived by his wife, as well as by a daughter and four sons.A deal was announced in May 2011 under which Cephalon would be acquired by Teva Pharmaceutical Industries in a deal valued at $6.8 billion.".
- Q5485165 birthDate "1953-05-13".
- Q5485165 birthPlace Q170433.
- Q5485165 birthYear "1953".
- Q5485165 deathDate "2010-12-16".
- Q5485165 deathPlace Q1345.
- Q5485165 deathYear "2010".
- Q5485165 wikiPageWikiLink Q1010244.
- Q5485165 wikiPageWikiLink Q112915.
- Q5485165 wikiPageWikiLink Q119697.
- Q5485165 wikiPageWikiLink Q1345.
- Q5485165 wikiPageWikiLink Q1420239.
- Q5485165 wikiPageWikiLink Q15427523.
- Q5485165 wikiPageWikiLink Q17012841.
- Q5485165 wikiPageWikiLink Q170433.
- Q5485165 wikiPageWikiLink Q179452.
- Q5485165 wikiPageWikiLink Q189561.
- Q5485165 wikiPageWikiLink Q192579.
- Q5485165 wikiPageWikiLink Q1951942.
- Q5485165 wikiPageWikiLink Q204711.
- Q5485165 wikiPageWikiLink Q206901.
- Q5485165 wikiPageWikiLink Q213600.
- Q5485165 wikiPageWikiLink Q221062.
- Q5485165 wikiPageWikiLink Q2398352.
- Q5485165 wikiPageWikiLink Q29496.
- Q5485165 wikiPageWikiLink Q410441.
- Q5485165 wikiPageWikiLink Q494192.
- Q5485165 wikiPageWikiLink Q5908783.
- Q5485165 wikiPageWikiLink Q60235.
- Q5485165 wikiPageWikiLink Q6647483.
- Q5485165 wikiPageWikiLink Q7163516.
- Q5485165 wikiPageWikiLink Q7214838.
- Q5485165 wikiPageWikiLink Q7351231.
- Q5485165 wikiPageWikiLink Q786713.
- Q5485165 wikiPageWikiLink Q8341432.
- Q5485165 wikiPageWikiLink Q8645634.
- Q5485165 wikiPageWikiLink Q8729143.
- Q5485165 wikiPageWikiLink Q8733292.
- Q5485165 wikiPageWikiLink Q8745359.
- Q5485165 wikiPageWikiLink Q8753520.
- Q5485165 wikiPageWikiLink Q8842160.
- Q5485165 wikiPageWikiLink Q898750.
- Q5485165 wikiPageWikiLink Q9155972.
- Q5485165 wikiPageWikiLink Q9690.
- Q5485165 wikiPageWikiLink Q9707746.
- Q5485165 dateOfBirth "1953-05-13".
- Q5485165 dateOfDeath "2010-12-16".
- Q5485165 name "Baldino, Frank Jr.".
- Q5485165 placeOfBirth Q170433.
- Q5485165 placeOfDeath "Philadelphia, Pennsylvania".
- Q5485165 shortDescription "Founder of Cephalon".
- Q5485165 type Person.
- Q5485165 type Agent.
- Q5485165 type Person.
- Q5485165 type Agent.
- Q5485165 type NaturalPerson.
- Q5485165 type Thing.
- Q5485165 type Q215627.
- Q5485165 type Q5.
- Q5485165 type Person.
- Q5485165 comment "Frank Baldino Jr. (May 13, 1953 – December 16, 2010) was an American pharmacologist and scientist who was one of the co-founders of the pharmaceutical firm Cephalon, a company that was formed in 1987 and had grown to annual sales of $2.8 billion and net income of $425 million in 2010.Baldino was born on May 13, 1953, in Passaic, New Jersey. He grew up in Bergen County, New Jersey and Bucks County, Pennsylvania, graduating from Pennsbury High School.".
- Q5485165 label "Frank Baldino, Jr.".
- Q5485165 givenName "Frank Jr.".
- Q5485165 name "Baldino, Frank Jr.".
- Q5485165 name "Frank Jr. Baldino".
- Q5485165 surname "Baldino".